‘UK Waiver’ For SPCs Proposed In Case Of No-Deal Brexit
Executive Summary
Draft legislation has been published by the UK’s Intellectual Property Office to ensure that the EU’s supplementary certificate protection manufacturing waiver will continue to function in the case of a no-deal Brexit outcome.
You may also be interested in...
UK’s No-Deal Brexit Plans For SPC Waiver Could Reduce IP Rights, Warns BIA
The UK’s plans to amend the supplementary protection certificate waiver legislation in the event of a no-deal Brexit could lead to the curtailment of IP protections, not only the terms of SPCs but regulatory data protection and orphan exclusivity too, the BIA claims.
Industry Prepares For Advent Of SPC Manufacturing Waiver
As the generics and biosimilars industries prepare for the European SPC manufacturing waiver to come into effect on 1 July, Generics Bulletin traces the history of the mechanism from early industry lobbying efforts to its ultimate entry into force.
EU SPC Waiver: Originators May Need To Act Soon
A new EU regulation relaxing the rules on generic and biosimilar manufacturing during a product’s supplementary protection certificate period will take effect on 1 July. Originator companies wanting to benefit from a three-year transition period should consider taking action now.